HB Wealth Management LLC Has $154,000 Stock Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

HB Wealth Management LLC lowered its stake in Aspen Aerogels, Inc. (NYSE:ASPN) by 39.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,974 shares of the construction company’s stock after selling 8,389 shares during the period. HB Wealth Management LLC’s holdings in Aspen Aerogels were worth $154,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Point72 Hong Kong Ltd acquired a new position in Aspen Aerogels in the second quarter valued at $84,000. Quent Capital LLC acquired a new stake in Aspen Aerogels during the third quarter worth approximately $118,000. Point72 DIFC Ltd bought a new stake in shares of Aspen Aerogels in the 2nd quarter valued at $121,000. nVerses Capital LLC grew its holdings in Aspen Aerogels by 45.0% in the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after purchasing an additional 1,800 shares during the period. Finally, Public Employees Retirement Association of Colorado bought a new stake in Aspen Aerogels in the second quarter valued at $145,000. Institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ASPN has been the topic of a number of research reports. Piper Sandler dropped their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Barclays cut their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. HC Wainwright restated a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. Finally, Roth Mkm cut their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $29.11.

Aspen Aerogels Stock Down 1.4 %

Shares of Aspen Aerogels stock opened at $11.50 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels, Inc. has a 52-week low of $10.75 and a 52-week high of $33.15. The company’s 50 day moving average price is $13.09 and its 200-day moving average price is $19.81. The stock has a market capitalization of $943.16 million, a price-to-earnings ratio of 1,150.65 and a beta of 2.14.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.